Correlations among Corneal Biomechanical Parameters, Stiffness, and Thickness Measured Using Corvis ST and Pentacam in Patients with Ocular Hypertension

Table 2

Clinical characteristics in OHT patients with glaucoma medication treatment.

	Baseline (mean (SD), n)	Eyes with topical treatment (mean (SD), n)	value
GAT IOP (mmHg)	25.69 (4.63), 35	17.03 (3.74), 35	<0.001^#
IOPnct (mmHg)	23.53 (7.47), 35	17.70 (2.84), 35	<0.001^#
bIOP (mmHg)	22.55 (6.62), 35	17.37 (2.44), 35	<0.001^#
BCVA (LogMAR)	0.24 (0.34), 35	0.23 (0.32), 35	0.97
Axial lengths (AL)	24.48 (1.38), 25	24.45 (1.37), 25	0.18
Corneal thickness in central pupil	545.71 (33.95), 35	544.31 (34.25), 35	0.096
Apex corneal thickness	545.74(33.52), 35	544.31 (32.42), 35	0.091
Minimum corneal thickness	541.54 (34.25), 35	540.23 (32.71), 35	0.108
PACH (μm)	547.34 (34.23), 35	544.29 (34.63), 35	0.014^#

Paired t-test for comparison of any difference at baseline and after medication. OHT: ocular hypertension; SD: standard deviation; GAT-IOP: Goldman applanation tonometer intraocular pressure; IOPnct: noncorrected IOP; bIOP: biomechanical corrected IOP value; BCVA: best corrected visual acuity, PACH: pachymetry, stands for CST corneal central thickness (CST CCT). ^#Significant differences were found by .